Diabetes Care, Vol 16, Issue 5 748-754, Copyright © 1993 by American Diabetes Association

ARTICLES

Racial differences in the relationship between blood pressure and risk of retinopathy among individuals with NIDDM

EL Harris, S Feldman, CR Robinson, S Sherman and A Georgopoulos
Department of Epidemiology, School of Hygiene and Public Health, Johns Hopkins University, Baltimore, Maryland.

OBJECTIVE--To assess whether the prevalence of retinopathy differs between blacks and whites with diabetes and to examine differences between blacks and whites in the relationship between risk factors for and prevalence of retinopathy. Population data suggest diabetic retinopathy is either more prevalent or more severe in blacks than in whites. RESEARCH DESIGN AND METHODS--We analyzed data from a screening study for retinopathy among patients with diabetes, conducted in Maryland from 1986-1990. RESULTS--After adjusting for age, duration of diabetes, type of treatment for diabetes, and presence or absence of high blood pressure, black men with NIDDM were approximately 23% more likely to have retinopathy than other race-sex groups (not statistically significant). We also found a different relationship between systolic blood pressure and retinopathy prevalence in blacks than in whites among individuals with NIDDM. Among blacks, the risk increased as systolic blood pressure increased, even within the normal range, and reached statistical significance at > 150 mmHg. Among whites, the risk was increased only among those with high systolic blood pressure (> 140 mmHg) and did not reach statistical significance. CONCLUSIONS--Our data are consistent with the hypothesis that differences exist between blacks and whites in risk of diabetic retinopathy, and that the effect of blood pressure on risk of retinopathy differs between blacks and whites.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. C. Leske, S.-Y. Wu, A. Hennis, B. Nemesure, A. P. Schachat, L. Hyman, L. Yang, and for the Barbados Eye Study Group Nine-year incidence of diabetic retinopathy in the barbados eye studies. Arch Ophthalmol, February 1, 2006; 124(2): 250 - 255. [Abstract] [Full Text] [PDF]

				L. C. Lanting, I. M.A. Joung, J. P. Mackenbach, S. W.J. Lamberts, and A. H. Bootsma Ethnic Differences in Mortality, End-Stage Complications, and Quality of Care Among Diabetic Patients: A review Diabetes Care, September 1, 2005; 28(9): 2280 - 2288. [Abstract] [Full Text] [PDF]

				N. Emanuele, J. Sacks, R. Klein, D. Reda, R. Anderson, W. Duckworth, C. Abraira, and for the Veterans Affairs Diabetes Trial Group Ethnicity, Race, and Baseline Retinopathy Correlates in the Veterans Affairs Diabetes Trial Diabetes Care, August 1, 2005; 28(8): 1954 - 1958. [Abstract] [Full Text] [PDF]

				T. S. Tang, M. L. Gillard, M. M. Funnell, R. Nwankwo, E. Parker, D. Spurlock, and R. M. Anderson Developing a New Generation of Ongoing Diabetes Self-management Support Interventions: A Preliminary Report The Diabetes Educator, January 1, 2005; 31(1): 91 - 97. [Abstract] [Full Text] [PDF]

				M. B. Davidson Effect of Nurse-Directed Diabetes Care in a Minority Population Diabetes Care, August 1, 2003; 26(8): 2281 - 2287. [Abstract] [Full Text] [PDF]

				S.-M. Herrmann, J. Ringel, J.-G. Wang, J. A. Staessen, and E. Brand Peroxisome Proliferator-Activated Receptor-{gamma}2 Polymorphism Pro12Ala Is Associated With Nephropathy in Type 2 Diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study Diabetes, August 1, 2002; 51(8): 2653 - 2657. [Abstract] [Full Text] [PDF]

				M. B. Davidson, V. J. Karlan, and T. L. Hair Effect of a Pharmacist-Managed Diabetes Care Program in a Free Medical Clinic American Journal of Medical Quality, July 1, 2000; 15(4): 137 - 142. [Abstract] [PDF]

				S. Vijan, T. P. Hofer, and R. A. Hayward Cost-Utility Analysis of Screening Intervals for Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus JAMA, February 16, 2000; 283(7): 889 - 896. [Abstract] [Full Text] [PDF]